Suggested Topics within your search.
Suggested Topics within your search.
- Drug Therapy 2
- Pharmaceutical Preparations 2
- Pharmacology 2
- administration & dosage 2
- Clinical Chemistry Tests 1
- Clinical chemistry 1
- Critical Care Nursing 1
- Critical Illness 1
- Human anatomy 1
- Human physiology 1
- Nursing 1
- Nursing Assessment 1
- Nursing Care 1
- Perioperative Nursing 1
- Physiological Phenomena 1
- Physiology 1
- Surgical nursing 1
- methods 1
- nursing 1
-
1101
Current perspectives and trends of the research on hypertensive nephropathy: a bibliometric analysis from 2000 to 2023
Published 2024-12-01Subjects: Get full text
Article -
1102
Graft survival and mortality outcomes after kidney transplant in patients with lupus nephritis: a systematic review and meta-analysis
Published 2024-12-01Subjects: Get full text
Article -
1103
-
1104
SOX9: a key transcriptional regulator in organ fibrosis
Published 2025-02-01Subjects: Get full text
Article -
1105
-
1106
Machine learning validation of the AVAS classification compared to ultrasound mapping in a multicentre study
Published 2025-01-01Subjects: Get full text
Article -
1107
PROFILE OF INCOMPATIBLE REACTIONS TO PACKED RED CELL TRANSFUSION IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT SANGLAH HOSPITAL
Published 2023-07-01Subjects: Get full text
Article -
1108
MSC-EXs inhibits uranium nephrotoxicity by competitively binding key proteins and inhibiting ROS production
Published 2025-01-01Subjects: Get full text
Article -
1109
-
1110
Intracapillary Monoclonal IgM Deposition Concomitant With Cold Agglutinin Disease
Published 2025-03-01Subjects: Get full text
Article -
1111
Role of Metformin in Preventing New-Onset Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus
Published 2025-01-01Subjects: Get full text
Article -
1112
Incomplete Currarino syndrome. Case presentation
Published 2023-07-01Subjects: “…enfermedades renales…”
Get full text
Article -
1113
Exceptional Response of Metastatic Chromophobe Renal Cell Carcinoma to Vascular Endothelial Growth Factor (VEGF) Inhibitors: Should Increased VEGF-C Expression Be Used to Guide Treatment?
Published 2019-01-01“…There is sparse literature demonstrating effective treatments for metastatic chromophobe renal cell carcinoma (ChRCC). The tyrosine kinase inhibitor (TKI) sunitinib selectively inhibits the VEGF pathway and it is a standard care for metastatic clear cell renal cell carcinoma (ccRCC), although data supporting its use in ChRCC is much more limited. …”
Get full text
Article -
1114
-
1115
-
1116
RETRACTED ARTICLE: P16INK4a Deletion Ameliorated Renal Tubulointerstitial Injury in a Stress-induced Premature Senescence Model of Bmi-1 Deficiency
Published 2017-08-01“…Abstract To determine whether p16INK4a deletion ameliorated renal tubulointerstitial injury by inhibiting a senescence-associated secretory phenotype (SASP) in Bmi-1-deficient (Bmi-1−/−) mice, renal phenotypes were compared among 5-week-old Bmi-1 and p16INK4a double-knockout, and Bmi-1−/− and wild-type mice. …”
Get full text
Article -
1117
-
1118
Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2: Effects on Intestinal Morphology and Absorption, Renal Function, Bone and Body Composition, and Muscle Function
Published 2009-01-01“…In addition, mucosal morphometrics, renal function (by creatinine clearance), body composition and bone mineral density (by DEXA), biochemical markers of bone turnover (by s-CTX and osteocalcin, PTH and vitamin D), and muscle function (NMR, lungfunction, exercise test) were measured. …”
Get full text
Article -
1119
Mouse Umbilical Cord Mesenchymal Stem Cell Paracrine Alleviates Renal Fibrosis in Diabetic Nephropathy by Reducing Myofibroblast Transdifferentiation and Cell Proliferation and Upregulating MMPs in Mesangial Cells
Published 2020-01-01“…However, the mechanisms by which UC-MSCs ameliorate renal fibrosis in DN are not well understood. Herein, we firstly investigated the therapeutic effects of mouse UC-MSC infusion on kidney structural and functional impairment in streptozotocin- (STZ-) induced diabetic mice. …”
Get full text
Article -
1120
Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register
Published 2012-07-01“…Objective To evaluate the effectiveness and safety of metformin use in clinical practice in a large sample of pharmacologically treated patients with type 2 diabetes and different levels of renal function.Design Observational study between July 2004 and December 2010, mean follow-up 3.9 years.Setting Hospital outpatient clinics and primary care in Sweden.Participants 51 675 men and women with type 2 diabetes, registered in the Swedish National Diabetes Register, and on continuous glucose-lowering treatment with oral hypoglycaemic agents (OHAs) or insulin.Main outcome measures Risks of cardiovascular disease (CVD), all-cause mortality and acidosis/serious infection, associated with each treatment regimens, were analysed in all patients and in subgroups with different estimated glomerular filtration rate (eGFR) intervals. …”
Get full text
Article